Final Results from a Phase 2 Study of Pracinostat in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Garcia-Manero, Guillermo [1 ]
Atallah, Ehab [2 ]
Khaled, Samer K. [3 ]
Arellano, Martha [4 ]
Patnaik, Mrinal M. [5 ]
Butler, Todd A. [6 ]
Ashby, Carla [6 ]
Medeiros, Bruno C. [7 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Med Coll Wisconsin, Dept Hematol Oncol, Milwaukee, WI 53226 USA
[3] City Hope Natl Med Ctr, Duarte, CA USA
[4] Emory Univ, Winship Canc Inst, Hematol Oncol, Atlanta, GA 30322 USA
[5] Mayo Clin, Div Hematol, Rochester, MN USA
[6] MEI Pharma Inc, San Diego, CA USA
[7] Stanford Univ, Stanford Comprehens Canc Ctr, Div Hematol Oncol, Stanford, CA 94305 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] UPDATED RESULTS FROM A PHASE 2 STUDY OF PRACINOSTAT (P) IN COMBINATION WITH AZACITIDINE (AZA) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Garcia-Manero, G.
    Atallah, E.
    Khaled, S.
    Arellano, M.
    Patnaik, M.
    Esquibel, V.
    Wood, K.
    Medeiros, B.
    HAEMATOLOGICA, 2015, 100 : 216 - 216
  • [2] Evaluation of the Correlation between Response and Duration of Treatment in a Phase 2 Study of Pracinostat Plus Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    Atallah, Ehab
    Medeiros, Bruno C.
    Khaled, Samer
    Patnaik, Mrinal M.
    Spezia, Riccardo
    Palmesino, Elena
    Garcia-Manero, Guillermo
    BLOOD, 2017, 130
  • [3] Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study
    Garcia-Manero, Guillermo
    Abaza, Yasmin
    Takahashi, Koichi
    Medeiros, Bruno C.
    Arellano, Martha
    Khaled, Samer K.
    Patnaik, Mrinal
    Odenike, Olatoyosi
    Sayar, Hamid
    Tummala, Mohan
    Patel, Prapti
    Maness-Harris, Lori
    Stuart, Robert
    Traer, Elie
    Karamlou, Kasra
    Yacoub, Abdulraheem
    Ghalie, Richard
    Giorgino, Ruben
    Atallah, Ehab
    BLOOD ADVANCES, 2019, 3 (04) : 508 - 518
  • [4] A Phase 2 Study of Pracinostat and Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Not Eligible for Induction Chemotherapy: Response and Long-Term Survival Benefit
    Manero, Guillermo Garcia
    Atallah, Ehab
    Khaled, Samer K.
    Arellano, Martha
    Patnaik, Mrinal M.
    Odenike, Olatoyosi
    Sayar, Hamid
    Tummala, Mohan
    Patel, Prapti A.
    Ghalie, Richard G.
    Medeiros, Bruno C.
    BLOOD, 2016, 128 (22)
  • [5] A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)
    Pollyea, Daniel A.
    Kohrt, Holbrook E.
    Gallegos, Leonel
    Berube, Caroline
    Coutre, Steven
    Gotlib, Jason
    Liedtke, Michaela
    Mitchell, Beverly S.
    Medeiros, Bruno C.
    BLOOD, 2010, 116 (21) : 1347 - 1347
  • [6] TREATMENT OF PRACINOSTAT AND AZACITIDINE IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): CORRELATION BETWEEN MUTATION CLEARANCE AND CLINICAL RESPONSE
    Takahashi, K.
    Abaza, Y.
    Wang, F.
    Gumbs, C.
    Xingzhi, S.
    Futreal, A.
    Atallah, E.
    Medeiros, B.
    Khaled, S.
    Arellano, M.
    Patnaik, M.
    Palmesino, E.
    Garcia-Manero, G.
    HAEMATOLOGICA, 2017, 102 : 51 - 52
  • [7] Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Pratz, Keith
    Potluri, Jalaja
    Pullarkat, Vinod
    Jonas, Brian A.
    Wei, Andrew H.
    Becker, Pamela S.
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel A.
    Letai, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S201 - S201
  • [8] Phase I Study of Pracinostat in Combination with Gemtuzumab Ozogamicin (PraGO) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Badar, Talha
    Murthy, Guru Subramanian Guru
    Runaas, Lyndsey
    Carlson, Karen-Sue B.
    Michaelis, Laura C.
    Harrington, Alexandra M.
    Atallah, Ehab L.
    Abedin, Sameem
    BLOOD, 2019, 134
  • [9] An early-phase study of azacitidine and lenalidomide for untreated elderly acute myeloid leukemia (AML) patients
    Pollyea, D. A.
    Kohrt, H. E.
    Rajwanshi, R.
    Gallegos, L.
    Berube, C.
    Coutre, S. E.
    Gotlib, J. R.
    Liedtke, M.
    Mitchell, B. S.
    Medeiros, B. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Correlation between mutation clearance and clinical response in elderly patients with acute myeloid leukemia (AML) treated with azacitidine and pracinostat.
    Takahashi, Koichi
    Abaza, Yasmin
    Atallah, Ehab L.
    Medeiros, Bruno C.
    Khal, Sam
    Arellano, Martha Lucia
    Patnaik, Mrinal
    Ghalie, Richard
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345